Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic β-cell-type KATP channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 1025-1032

  Chachin, Motohiko ^a   Yamada, Mitsuhiko ^a   Fujita, Akikazu ^b   Matsuoka, Tetsuro ^a   Matsushita, Kenji ^a   Kurachi, Yoshihisa ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE MAGNESIUM; BENZAMIDE DERIVATIVE; DEXTRO PHENYLALANINE; NATEGLINIDE; POTASSIUM CHANNEL; SERINE; SULFONYLUREA DERIVATIVE; SULFONYLUREA RECEPTOR; TYROSINE; URIDINE DIPHOSPHATE;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; HUMAN; HUMAN CELL; PANCREAS ISLET BETA CELL; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL;

ADENOSINE DIPHOSPHATE; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CYCLOHEXANES; ELECTROPHYSIOLOGY; HUMANS; ISLETS OF LANGERHANS; PHENYLALANINE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; SULFONYLUREA COMPOUNDS;

EID: 0037371267     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.044917     Document Type: Article

References (39)

1. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP 4th, Boyd AE 3rd, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J, and Nelson DA (1995) Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science (Wash DC) 268:423-426.
2. Akiyoshi M, Kakei M, Nakazaki M, and Tanaka H (1995) A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells. Am J Physiol 268: E185-E193.
3. Ashcroft FM (1988) Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 11:97-118.
4. Ashfield R, Gribble FM, Ashcroft SJH, and Ashcroft FM (1999) Identification of the high-affinity tolbutamide site on the SUR1 subunit of the KATP channel. Diabetes 48:1341-1347.
5. + channel blocking agent glibenclamide on ischaemic and reperfusion arrhythmias. Eur J Pharmacol 326:147-156.
6. ATP channel complex. FASEB J 14:1943-1952.
7. ATP channels. Pharmacologist 44 (Suppl 1):A154.95.12.
8. ATP channel subunits. Neuron 18:827-838.
9. Cleveland JC Jr, Meldrum DR, Cain BS, Banerjee A, and Harken AH (1997) Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 96:29-32.
10. ATP channels to gliclazide. Diabetologia 42:845-848.
11. Gribble FM, Manley SE, and Levy JC (2001) Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). Diabetes Care 24:1221-1225.
12. + channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol (Lond) 504:35-45.
13. Gribble FM, Tucker SJ, and Ashcroft FM (1997b) The essential role of the Walker A motifs of SUR1 in K-ATP channel activation by Mg-ADP and diazoxide. EMBO (Eur Mol Biol Organ) J 16:1145-1152.
14. ATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci USA 95:7185-7190.
15. ATP channels. Diabetes 47: 1412-1418.
16. Hansen AM, Christensen IT, Hansen JB, Carr RD, Ashcroft FM, and Wahl P (2002) Differential interactions of nateglinide and repaglinide on the human β-cell sulphonylurea receptor 1. Diabetes 51:2789-2795.
17. Hu S, Wang S, and Dunning BE (1999) Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and β-cell KATP channels. J Pharmacol Exp Ther 291:1372-1379.
18. Ikenoue T, Akiyoshi M, Fujitani S, Okazaki K, Kondo N, and Maki T (1997) Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N- (trans.4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). Br J Pharmacol 120:137-145.
19. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science (Wash DC) 270:1166-1170.
20. + channels. Neuron 16:1011-1017.
21. + channel. FEBS Lett 409:232-236.
22. + channel. J Biol Chem 271:24321-24324.
23. Lins L, Brasseur R, and Malaisse WJ (1995) Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family. Biochem Pharmacol 50:1879-1884.
24. + channels. Circ Res 87:873-880.
25. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, and Seino S (2002) Mouse model of prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8:466-472.
26. Nichols CG, Shyng SL, Nestorowicz A, Glaser B, Clement JP IV, Gonzalez G, Aguilar-Bryan L, Permutt MA, and Bryan J (1996) Adenosine diphosphate as an intracellular regulator of insulin secretion. Science (Wash DC) 272:1785-1787.
27. Quayle JM, Nelson MT, and Standen NB (1997) ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165-1232.
28. Reimann F, Proks P, and Ashcroft FM (2001) Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. Br J Pharmacol 132:1542-1548.
29. Sakura H, Ammälä C, Smith PA, Gribble FM, and Ashcroft FM (1995) Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 377:338-344.
30. + channel in mouse pancreatic B cells by their combined actions at inhibitory and stimulatory receptors. Mol Pharmacol 41:480-486.
31. ATP channel complex. J Gen Physiol 110:655-664.
32. + channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Eur J Pharmacol 431:119-125.
33. + channel-opening drugs. Am J Physiol 269:C525-C545.
34. ATP channel inhibition by ATP. EMBO (Eur Mol Biol Organ) J 17:3290-3296.
35. + channels in the absence of the sulphonylurea receptor. Nature (Lond) 387:179-183.
36. UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853.
37. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, and Inagaki N (2001) Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science (Wash DC) 292:1543-1546.
38. + channel. J Physiol (Lond) 499:715-720.
39. + channels from pancreatic B-cells. FEBS Lett 239:241-244.